The nation’s top drug regulator has officially changed how it regulates CBD, a marijuana compound that’s in a new epilepsy drug called Epidiolex. This is the first time in 46 years that the Drug Enforcement Administration has shifted its stance on cannabis. The DEA’s move comes after Epidiolex was greenlit […]
On a call with investors this week, GW Pharmaceuticals revealed the price of Epidiolex, its newly-approved, marijuana-based drug for rare forms of epilepsy. Designed to treat two rare forms of childhood epilepsy using a marijuana compound called CBD, the drug is the first medication of its kind to get FDA […]
This week’s historic decision by the Food and Drug Administration to approve Epidiolex, the first prescription drug derived from marijuana, has left cannabis startups in a tough spot. Although many welcome the approval as a sign of the growing recognition of marijuana’s potential health benefits, some also worry that it […]
Change is coming for a small but blooming corner of the marijuana industry. Cannabidiol, or CBD, is a marijuana compound that has been linked to a range of potential health benefits but does not get you high. The roughly $US1 billion CBD industry is slated to shift into high gear […]
A drug derived from marijuana to treat epilepsy is on the brink of becoming the first of its kind to win US government approval. The drug, called Epidiolex, contains a compound in cannabis that is not responsible for a high called CBD. In its third positive clinical trial, the drug […]
